The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2011 and 2015. Materials and Methods We analyzed the claims data from the Health Insurance Review and Assessment Service to estimate the clinical utilization of RT. The source population consisted of all patients who had any of the International Classification of Diseases 10th revision cancer diagnoses (C00- C97) and those with diagnostic codes D00-D48, who were also associated with at least one of the procedure codes related to RT. Results The total number of patients who received RT in 2011, 2012, 2013, 2014, and 2015 were 54,810, 59,435, 61,839, 64,062, and 66,183, respectively. Among them, the total numbers of male and female patients were 24,946/29,864 in 2011, 27,211/32,224 in 2012, 28,111/33,728 in 2013, 29,312/34,750 in 2014, and 30,266/35,917 in 2015. The utilization rate of RT in cancer patients has also increased steadily over the same period from 25% to 30%. The five cancers that were most frequently treated with RT between 2011 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. More than half of cancer patients (64%) were treated with RT in the capital area (Seoul, Gyeonggi, and Incheon). Conclusion The total number of patients who underwent RT increased steadily from 2011 to 2015 in Korea. The utilization rate of RT in cancer patients is also increasing.
Abstract
Purpose The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2011 and 2015. Materials and Methods We analyzed the claims data from the Health Insurance Review and Assessment Service to estimate the clinical utilization of RT. The source population consisted of all patients who had any of the International Classification of Diseases 10th revision cancer diagnoses (C00- C97) and those with diagnostic codes D00-D48, who were also associated with at least one of the procedure codes related to RT. Results The total number of patients who received RT in 2011, 2012, 2013, 2014, and 2015 were 54,810, 59,435, 61,839, 64,062, and 66,183, respectively. Among them, the total numbers of male and female patients were 24,946/29,864 in 2011, 27,211/32,224 in 2012, 28,111/33,728 in 2013, 29,312/34,750 in 2014, and 30,266/35,917 in 2015. The utilization rate of RT in cancer patients has also increased steadily over the same period from 25% to 30%. The five cancers that were most frequently treated with RT between 2011 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. More than half of cancer patients (64%) were treated with RT in the capital area (Seoul, Gyeonggi, and Incheon). Conclusion The total number of patients who underwent RT increased steadily from 2011 to 2015 in Korea. The utilization rate of RT in cancer patients is also increasing.
참고문헌 (19)
- [URL]
- Slotman BJ, "Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1", Radiother Oncol, 75, pp.349~354 (2005)
- 강진규, "The clinical utilization of radiation therapy in Korea between 2009 and 2013", Radiation oncology journal, 34(2), pp.88~95 (2016), 대한방사선종양학회
- 강진규, "The Clinical Status of Radiation Therapy in Korea in 2009 and 2013", Cancer Research and Treatment, 48(3), pp.892~898 (2016), 대한암학회
- [URL]
- Lee N, "The role of external beam radiotherapy in the treatment of papillary thyroid cancer", Endocr Relat Cancer, 13, pp.971~977 (2006)[DOI]
- Park SH, "Technical advances in external radiotherapy for hepatocellular carcinoma", World J Gastroenterol, 22, pp.7311~7321 (2016)[DOI]
- Kang JK, "Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization", Cancer, 118, pp.5424~5431 (2012)[DOI]
- Paik EK, "Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma", Radiat Oncol, 11, pp.22~ (2016)[DOI]
- 임채홍, "Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines", Radiation oncology journal, 34(3), pp.160~167 (2016), 대한방사선종양학회
- 배봉경, "The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy", Radiation oncology journal, 34(3), pp.168~176 (2016), 대한방사선종양학회
- 설승원, "Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma", Radiation oncology journal, 33(4), pp.276~283 (2015), 대한방사선종양학회
- 한국 간 암 스터디그룹, "2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma", Gut and Liver, 9(3), pp.267~317 (2015), 거트앤리버 소화기연관학회협의회
- Barton MB, "Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012", Radiother Oncol, 112, pp.140~144 (2014)[DOI]
- Borras JM, "The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis", Radiother Oncol, 116, pp.38~44 (2015)[DOI]
- Rosenblatt E, "Optimal radiotherapy utilisation rate in developing countries: An IAEA study", Radiother Oncol, 116, pp.35~37 (2015)[DOI]
- Mackillop WJ, "A comparison of evidencebased estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in ontario", Int J Radiat Oncol Biol Phys, 91, pp.1099~1107 (2015)[DOI]
- 정광주, "The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center", Radiation oncology journal, 33(4), pp.337~343 (2015), 대한방사선종양학회
- Huh SJ, "Current status of the infrastructure and characteristics of radiation oncology in Korea", Jpn J Clin Oncol, 37, pp.623~627 (2007)[DOI]